Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNS vs Topiramate for Migraine Prevention
NCT05516251Unknown
- Sponsor
- Tongji Hospital
- Start
- Oct 2021
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Tongji Hospital. Primary endpoints: Change from baseline in the number of migraine days at 3 months, Change from baseline in the number of moderate/severe headache days at 3 months and 1 more. Status: unknown.
Beyond the preview
Go deeper on NCT05516251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05516251.